Remove publications
article thumbnail

FDA Releases Plan To Obtain Data Regarding Cannabis-Derived Product Usage & Safety

Cannabis Law Report

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Instead, the FDA recognizes that “the growth of the [cannabis-derived product] market continues to outpace the growth in the science and our understanding of the public health implications of these products.”

Safety 52
article thumbnail

Public Safety Canada: Announcement On Enforcement of Illegal Cannabis

Cannabis Law Report

Public Safety (PS) is supporting efforts to enforce the legalization and regulation of cannabis through activities to deter criminal activity and to help ensure that organized crime does not penetrate the legalized system.

Safety 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Data Analysis Yields Insights Into Medical Cannabis Use, Efficacy

Cannabis Law Report

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.

Data 105
article thumbnail

Does Legal Cannabis Increase Your Home’s Value? This Data Says So

Cannabis Law Report

According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Public health and safety programs. General funds.

Data 116
article thumbnail

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.

Safety 52
article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52
article thumbnail

US Hemp Round Table: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.

Safety 52